NOV 17, 2015 8:00 AM PST

Unleashing the power of biobanks to drive translational science forward

Speakers
  • Biorefinery Scientist, Integrated Biobank of Luxembourg
    Biography
      Dr. Mathay's research background is molecular cell biology with a specialization in dermatology. She holds a PhD in Biomedical and Pharmaceutical Sciences from the University of Namur (Belgium).
      Her background includes "Specialized Studies in Applied Biological Sciences (DES)" including traineeships at the Karolinska Institutet in Stockholm and the Agricultural University of Gembloux (GxABT). She worked previously in transdisciplinary applied medical research projects from the Région Wallonne.
      In 2010, Dr. Mathay joined the Integrated Biobank of Luxembourg as Biorefinery Scientist. In IBBL she is organizing and supervising activities of the Biorefinery and Biospecimen Research laboratory and is deeply involved in Lab Automation, Quality Control and Validation of Analytical Laboratory Methods. Important publications include fundamental dermatology research publications and method validation papers.
      Dr. Mathay will discuss automation of nucleic acid extraction of two Biobanking workflows. The JANUS® chemagic automated workstation is a robust and quick magnetic beads-based nucleic acid extraction method which permits to process different sample types and volumes. The DNA extraction workflows were formally validated the DNA extraction workflows from human blood and stool and this presentation will illustrate the advantages of automated sample handling and extraction of DNA from blood and stool samples and their related formal method validation.
    • Professor of Genetics Rutgers University; COO RUCDR Infinite Biologics; CSO Brooks Life Sciences
      Biography
        Dr. Andy Brooks is the Chief Operating Officer and Director of Technology Development of RUCDR Infinite Biologics at Rutgers University. As the COO, Dr. Brooks oversees the operations of all laboratories within RUCDR, ensuring consistent and superior quality standards for all services. RUCDR Infinite Biologics, is the world's largest university-based biorepository with a focus on creating and implementing technologies for biomaterial quality control and sample chain of custody. Dr. Brooks is a molecular neuroscientist, whose research focuses on deciphering the molecular mechanisms that underlie memory and learning. Dr. Brooks is a well-recognized genomicist and has been involved in the development and implementation of cutting edge molecular based technologies for both nucleic acid and protein analyses. He has worked to automate and develop the service infrastructure to provide high-throughput sample management and analysis for DNA, RNA, and protein-based technologies to hundreds of labs globally.
      • Director of Strategic Marketing, PerkinElmer Informatics
        Biography
          Jens Hoefkens oversees the non-clinical life science informatics portfolio at PerkinElmer. His responsibilities cover the TIBCO® Spotfire franchise, the Enterprise R&D collaboration platforms, and the Signals data management platform. Jens has over a decade of experience in running successful bioinformatics businesses with a special emphasis on drug discovery, translational research, and cross-OMICS data integration Prior to joining PerkinElmer, Jens was the Head of the Expressionist business unit at Genedata, where he managed all aspects of the business, including sales, marketing, services, and software development. In that role Jens successfully expanded the Expressionist product line to include support for Next Generation Sequencing and Mass Spectrometry data. Jens holds a dual major PhD in Mathematics and Physics from Michigan State University.
          In this webinar, Dr. Hoefkens will present PerkinElmer Signals® a cloud-based data management platform that has been designed with flexible and scalable data models to provide the scalability and agility required to support modern life science research. To illustrate the versatility of the platform, we look at examples in areas as varied as Translational Medicine and High Content Screening.

        Abstract
        DATE: November 17th, 2015
        TIME: 8am PDT, 11am EDT, 4pm GMT

        Biobanks provide important capacity to collect large genomic data sets intended to enable the study of genetic signatures of an identified population. An essential step in genetic research is the isolation of high quality DNA or RNA. Many downstream biobanking applications are adversely affected by untreated or poor quality sample. Large amounts of cellular or other contaminating materials in complex mixtures often hinder many of the subsequent reactions and techniques. Thus, a method for the efficient, reliable and reproducible isolation of nucleic acids from complex biological mixtures is essential. This webinar presents innovative nucleic acid extraction technologies that help ensure high purity, high yield DNA/RNA. Speakers will also offer techniques for remote analysis and comparison of resulting data by multiple research groups in a biobanking workflow.

        Show Resources
        You May Also Like
        APR 07, 2020 8:00 AM PDT
        C.E. CREDITS
        APR 07, 2020 8:00 AM PDT
        DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
        OCT 08, 2020 7:00 AM PDT
        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
        C.E. CREDITS
        OCT 08, 2020 7:00 AM PDT
        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
        DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
        JUN 23, 2020 10:00 AM PDT
        C.E. CREDITS
        JUN 23, 2020 10:00 AM PDT
        DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
        APR 27, 2020 9:00 AM PDT
        C.E. CREDITS
        APR 27, 2020 9:00 AM PDT
        DATE: April 27, 2020 TIME: 9:00am PT, 12:00pm ET Recombinant adeno-associated virus (rAAV) is a small (25-nm) virus that is composed of a protein shell called a capsid and a single-stranded...
        FEB 26, 2020 9:00 AM PST
        C.E. CREDITS
        FEB 26, 2020 9:00 AM PST
        DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
        MAY 08, 2020 10:00 AM PDT
        C.E. CREDITS
        MAY 08, 2020 10:00 AM PDT
        DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
        Loading Comments...
        Show Resources
        Attendees
        • See more